AstraZeneca to Acquire Gracell in $1.2 Billion Deal to Further Cell Therapy Goals

AstraZeneca announced Tuesday it would acquire Gracell Biotechnologies in a deal valued at up to $1.2 billion.#astrazeneca
Source: Reuters: Health - Category: Consumer Health News Source Type: news